Exploring mitochondrial system properties of neurodegenerative diseases through interactome mapping

Journal of Proteomics

Volumn 100, Issue , 2014, Pages 8-24

  Vlasblom, James ^a   Jin, Ke ^a,b,c   Kassir, Sandy ^a   Babu, Mohan ^a  

^a UNIVERSITY OF REGINA   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Epistatic interactions; Mitochondrial diseases; Networks; Neurodegenerative diseases; Protein protein interactions; RNA interference

Indexed keywords

MITOCHONDRIAL PROTEIN;

AFFINITY PURIFICATION MASS SPECTROMETRY; BIOCHEMISTRY; BRAIN MITOCHONDRION; CELLULAR, SUBCELLULAR AND MOLECULAR BIOLOGICAL PHENOMENA AND FUNCTIONS; DEGENERATIVE DISEASE; FRACTIONATION; FUNCTIONAL PROTEOMICS; GENE INTERACTION; GENOMICS; HIGH THROUGHPUT GENOMICS; HUMAN; INTERACTOME MAPPING; MASS SPECTROMETRY; MITOCHONDRIAL SYSTEM; MITOCHONDRIAL SYSTEM PROPERTY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; REVIEW; TWO HYBRID SYSTEM; MITOCHONDRION; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; PROTEOMICS;

EUKARYOTA; PROKARYOTA;

HUMANS; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; NEURODEGENERATIVE DISEASES; PROTEIN INTERACTION MAPPING; PROTEOMICS;

EID: 84897045244     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2013.11.008     Document Type: Review

References (155)

1. Calvo S.E., Mootha V.K. The mitochondrial proteome and human disease. Annu Rev Genomics Hum Genet 2010, 11:25-44.
2. Nunnari J., Suomalainen A. Mitochondria: in sickness and in health. Cell 2012, 148:1145-1159.
3. Hess D.C., Myers C.L., Huttenhower C., Hibbs M.A., Hayes A.P., Paw J., et al. Computationally driven, quantitative experiments discover genes required for mitochondrial biogenesis. PLoS Genet 2009, 5:e1000407.
4. Perocchi F., Jensen L.J., Gagneur J., Ahting U., von Mering C., Bork P., et al. Assessing systems properties of yeast mitochondria through an interaction map of the organelle. PLoS Genet 2006, 2:e170.
5. Chen X., Li J., Hou J., Xie Z., Yang F. Mammalian mitochondrial proteomics: insights into mitochondrial functions and mitochondria-related diseases. Expert Rev Proteomics 2010, 7:333-345.
6. Meissner W.G., Frasier M., Gasser T., Goetz C.G., Lozano A., Piccini P., et al. Priorities in Parkinson's disease research. Nat Rev Drug Discov 2011, 10:377-393.
7. Gaston D., Tsaousis A.D., Roger A.J. Predicting proteomes of mitochondria and related organelles from genomic and expressed sequence tag data. Methods Enzymol 2009, 457:21-47.
8. Mootha V.K., Lepage P., Miller K., Bunkenborg J., Reich M., Hjerrild M., et al. Identification of a gene causing human cytochrome c oxidase deficiency by integrative genomics. Proc Natl Acad Sci U S A 2003, 100:605-610.
9. Pagliarini D.J., Calvo S.E., Chang B., Sheth S.A., Vafai S.B., Ong S.E., et al. A mitochondrial protein compendium elucidates complex I disease biology. Cell 2008, 134:112-123.
10. Sickmann A., Reinders J., Wagner Y., Joppich C., Zahedi R., Meyer H.E., et al. The proteome of Saccharomyces cerevisiae mitochondria. Proc Natl Acad Sci U S A 2003, 100:13207-13212.
11. Schmidt O., Pfanner N., Meisinger C. Mitochondrial protein import: from proteomics to functional mechanisms. Nat Rev Mol Cell Biol 2010, 11:655-667.
12. Baker M.J., Tatsuta T., Langer T. Quality control of mitochondrial proteostasis. Cold Spring Harb Perspect Biol 2011, 3.
13. Hoppins S., Collins S.R., Cassidy-Stone A., Hummel E., Devay R.M., Lackner L.L., et al. A mitochondrial-focused genetic interaction map reveals a scaffold-like complex required for inner membrane organization in mitochondria. J Cell Biol 2011, 195:323-340.
14. Jeon J., Jeong J.H., Baek J.H., Koo H.J., Park W.H., Yang J.S., et al. Network clustering revealed the systemic alterations of mitochondrial protein expression. PLoS Comput Biol 2011, 7:e1002093.
15. Liesa M., Palacin M., Zorzano A. Mitochondrial dynamics in mammalian health and disease. Physiol Rev 2009, 89:799-845.
16. Beltrao P., Cagney G., Krogan N.J. Quantitative genetic interactions reveal biological modularity. Cell 2010, 141:739-745.
17. Boone C., Bussey H., Andrews B.J. Exploring genetic interactions and networks with yeast. Nat Rev Genet 2007, 8:437-449.
18. Krogan N.J., Cagney G., Yu H., Zhong G., Guo X., Ignatchenko A., et al. Global landscape of protein complexes in the yeast Saccharomyces cerevisiae. Nature 2006, 440:637-643.
19. Babu M., Vlasblom J., Pu S., Guo X., Graham C., Bean B.D.M., et al. Interaction landscape of membrane-protein complexes in Saccharomyces cerevisiae. Nature 2012, 489:585-589.
20. Uetz P., Giot L., Cagney G., Mansfield T.A., Judson R.S., Knight J.R., et al. A comprehensive analysis of protein-protein interactions in Saccharomyces cerevisiae. Nature 2000, 623-627.
21. Babu M., Díaz-Mejía J.J., Vlasblom J., Gagarinova A., Phanse S., Graham C., et al. Genetic interaction maps in Escherichia coli reveal functional crosstalk among cell envelope biogenesis pathways. PLoS Genet 2011, 7:e1002377.
22. Butland G., Babu M., Díaz-Mejía J.J., Bohdana F., Phanse S., Gold B., et al. eSGA: E. coli synthetic genetic array analysis. Nat Methods 2008, 5:789-795.
23. Hu P., Janga S.C., Babu M., Diaz-Mejia J.J., Butland G. Global functional atlas of Escherichia coli encompassing previously uncharacterized proteins. PLoS Biol 2009, 7:e1000096.
24. Lehner B., Crombie C., Tischler J., Fortunato A., Fraser A.G. Systematic mapping of genetic interactions in Caenorhabditis elegans identifies common modifiers of diverse signaling pathways. Nat Genet 2006, 38:896-903.
25. Polanowska J., Martin J.S., Fisher R., Scopa T., Rae I., Boulton S.J. Tandem immunoaffinity purification of protein complexes from Caenorhabditis elegans. Biotechniques 2004, 36:778-780. [80].
26. Guruharsha K.G., Rual J.F., Zhai B., Mintseris J., Vaidya P., Vaidya N., et al. A protein complex network of Drosophila melanogaster. Cell 2011, 147:690-703.
27. Horn T., Sandmann T., Fischer B., Axelsson E., Huber W., Boutros M. Mapping of signaling networks through synthetic genetic interaction analysis by RNAi. Nat Methods 2011, 8:341-346.
28. Bassik M.C., Kampmann M., Lebbink R.J., Wang S., Hein M.Y., Poser I., et al. A systematic mammalian genetic interaction map reveals pathways underlying ricin susceptibility. Cell 2013, 152:909-922.
29. Havugimana P.C., Hart G.T., Nepusz T., Yang H., Turinsky A.L., Li Z., et al. A census of human soluble protein complexes. Cell 2012, 150:1068-1081.
30. Laufer C., Fischer B., Billmann M., Huber W., Boutros M. Mapping genetic interactions in human cancer cells with RNAi and multiparametric phenotyping. Nat Methods 2013, 10:427-431.
31. Mak A.B., Ni Z., Hewel J.A., Chen G.I., Zhong G., Karamboulas K., et al. A lentiviral functional proteomics approach identifies chromatin remodeling complexes important for the induction of pluripotency. Mol Cell Proteomics 2010, 9:811-823.
32. Roguev A., Talbot D., Negri G.L., Shales M., Cagney G., Bandyopadhyay S., et al. Quantitative genetic-interaction mapping in mammalian cells. Nat Methods 2013, 10:432-437.
33. Sowa M.E., Bennett E.J., Gygi S.P., Harper J.W. Defining the human deubiquitinating enzyme interaction landscape. Cell 2009, 138:389-403.
34. Lievens S., Vanderroost N., Van der Heyden J., Gesellchen V., Vidal M., Tavernier J. Array MAPPIT: high-throughput interactome analysis in mammalian cells. J Proteome Res 2009, 8:877-886.
35. Lievens S., Lemmens I., Tavernier J. Mammalian two-hybrids come of age. Trends Biochem Sci 2009, 34:579-588.
36. Yu H., Braun P., Yildirim M.A., Lemmens I., Venkatesan K., Sahalie J., et al. High-quality binary protein interaction map of the yeast interactome network. Science 2008, 322:104-110.
37. Costanzo M., Baryshnikova A., Bellay J., Kim Y., Spear E.D., Sevier C.S., et al. The genetic landscape of a cell. Science 2010, 327:425-431.
38. Mohr S., Bakal C., Perrimon N. Genomic screening with RNAi: results and challenges. Annu Rev Biochem 2010, 79:37-64.
39. Bassik M.C., Lebbink R.J., Churchman L.S., Ingolia N.T., Patena W., LeProust E.M., et al. Rapid creation and quantitative monitoring of high coverage shRNA libraries. Nat Methods 2009, 6:443-445.
40. Bandyopadhyay S., Kelley R., Krogan N.J., Ideker T. Functional maps of protein complexes from quantitative genetic interaction data. PLoS Comput Biol 2008, 4:e1000065.
41. Barabasi A.L., Gulbahce N., Loscalzo J. Network medicine: a network-based approach to human disease. Nat Rev Genet 2011, 12:56-68.
42. Oti M., Snel B., Huynen M.A., Brunner H.G. Predicting disease genes using protein-protein interactions. J Med Genet 2006, 43:691-698.
43. Hebert D.N., Molinari M. In and out of the ER: protein folding, quality control, degradation, and related human diseases. Physiol Rev 2007, 87:1377-1408.
44. Israelson A., Arbel N., Da Cruz S., Ilieva H., Yamanaka K., Shoshan-Barmatz V., et al. Misfolded mutant SOD1 directly inhibits VDAC1 conductance in a mouse model of inherited ALS. Neuron 2010, 67:575-587.
45. Xiong H., Wang D., Chen L., Choo Y.S., Ma H., Tang C., et al. Parkin, PINK1, and DJ-1 form a ubiquitin E3 ligase complex promoting unfolded protein degradation. J Clin Invest 2009, 119:650-660.
46. Li H., Guo M. Protein degradation in Parkinson disease revisited: it's complex. J Clin Invest 2009, 119:442-445.
47. Sarraf S.A., Raman M., Guarani-Pereira V., Sowa M.E., Huttlin E.L., Gygi S.P., et al. Landscape of the PARKIN-dependent ubiquitylome in response to mitochondrial depolarization. Nature 2013, 496:372-376.
48. Youle R.J., Narendra D.P. Mechanisms of mitophagy. Nat Rev Mol Cell Biol 2011, 12:9-14.
49. Wang X., Su B., Liu W., He X., Gao Y., Castellani R.J., et al. DLP1-dependent mitochondrial fragmentation mediates 1-methyl-4-phenylpyridinium toxicity in neurons: implications for Parkinson's disease. Aging Cell 2011, 10:807-823.
50. Chen H., McCaffery J.M., Chan D.C. Mitochondrial fusion protects against neurodegeneration in the cerebellum. Cell 2007, 130:548-562.
51. Chen H., Chan D.C. Critical dependence of neurons on mitochondrial dynamics. Curr Opin Cell Biol 2006, 18:453-459.
52. Palmer C.S., Osellame L.D., Stojanovski D., Ryan M.T. The regulation of mitochondrial morphology: intricate mechanisms and dynamic machinery. Cell Signal 2011, 23:1534-1545.
53. Misko A., Jiang S., Wegorzewska I., Milbrandt J., Baloh R.H. Mitofusin 2 is necessary for transport of axonal mitochondria and interacts with the Miro/Milton complex. J Neurosci 2010, 30:4232-4240.
54. Um J.W., Stichel-Gunkel C., Lubbert H., Lee G., Chung K.C. Molecular interaction between parkin and PINK1 in mammalian neuronal cells. Mol Cell Neurosci 2009, 40:421-432.
55. Yonashiro R., Sugiura A., Miyachi M., Fukuda T., Matsushita N., Inatome R., et al. Mitochondrial ubiquitin ligase MITOL ubiquitinates mutant SOD1 and attenuates mutant SOD1-induced reactive oxygen species generation. Mol Biol Cell 2009, 20:4524-4530.
56. Goh K.I., Cusick M.E., Valle D., Childs B., Vidal M., Barabasi A.L. The human disease network. Proc Natl Acad Sci U S A 2007, 104:8685-8690.
57. Amberger J., Bocchini C.A., Scott A.F., Hamosh A. McKusick's Online Mendelian Inheritance in Man (OMIM). Nucleic Acids Res 2009, 37:D793-D796.
58. Boeckmann B., Bairoch A., Apweiler R., Blatter M.C., Estreicher A., Gasteiger E., et al. The SWISS-PROT protein knowledgebase and its supplement TrEMBL in 2003. Nucleic Acids Res 2003, 31:365-370.
59. Elstner M., Andreoli C., Klopstock T., Meitinger T., Prokisch H. The mitochondrial proteome database: MitoP2. Methods Enzymol 2009, 457:3-20.
60. Becker K.G., Barnes K.C., Bright T.J., Wang S.A. The genetic association database. Nat Genet 2004, 36:431-432.
61. Stenson P.D., Mort M., Ball E.V., Howells K., Phillips A.D., Thomas N.S., et al. The Human Gene Mutation Database: 2008 update. Genome Med 2009, 1:13.
62. Krogh A., Larsson B., von Heijne G., Sonnhammer E.L. Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J Mol Biol 2001, 305:567-580.
63. Bernsel A., Viklund H., Falk J., Lindahl E., von Heijne G., Elofsson A. Prediction of membrane-protein topology from first principles. Proc Natl Acad Sci U S A 2008, 105:7177-7181.
64. Kall L., Krogh A., Sonnhammer E.L. A combined transmembrane topology and signal peptide prediction method. J Mol Biol 2004, 338:1027-1036.
65. Sammut S.J., Finn R.D., Bateman A. Pfam 10years on: 10,000 families and still growing. Brief Bioinform 2008, 9:210-219.
66. Oliver S. Guilt-by-association goes global. Nature 2000, 403:601-603.
67. Fulda S., Galluzzi L., Kroemer G. Targeting mitochondria for cancer therapy. Nat Rev Drug Discov 2010, 9:447-464.
68. Andreux P.A., Houtkooper R.H., Auwerx J. Pharmacological approaches to restore mitochondrial function. Nat Rev Drug Discov 2013, 12:465-483.
69. Girard C., Liu S., Cadepond F., Adams D., Lacroix C., Verleye M., et al. Etifoxine improves peripheral nerve regeneration and functional recovery. Proc Natl Acad Sci U S A 2008, 105:20505-20510.
70. Bordet T., Buisson B., Michaud M., Drouot C., Galea P., Delaage P., et al. Identification and characterization of cholest-4-en-3-one, oxime (TRO19622), a novel drug candidate for amyotrophic lateral sclerosis. J Pharmacol Exp Ther 2007, 322:709-720.
71. Eckert G.P., Renner K., Eckert S.H., Eckmann J., Hagl S., Abdel-Kader R.M., et al. Mitochondrial dysfunction - a pharmacological target in Alzheimer's disease. Mol Neurobiol 2012, 46:136-150.
72. Smith R.A., Hartley R.C., Cocheme H.M., Murphy M.P. Mitochondrial pharmacology. Trends Pharmacol Sci 2012, 33:341-352.
73. Galluzzi L., Kepp O., Tajeddine N., Kroemer G. Disruption of the hexokinase-VDAC complex for tumor therapy. Oncogene 2008, 27:4633-4635.
74. Goldin N., Arzoine L., Heyfets A., Israelson A., Zaslavsky Z., Bravman T., et al. Methyl jasmonate binds to and detaches mitochondria-bound hexokinase. Oncogene 2008, 27:4636-4643.
75. Szewczyk A., Wojtczak L. Mitochondria as a pharmacological target. Pharmacol Rev 2002, 54:101-127.
76. Moffat J., Grueneberg D.A., Yang X., Kim S.Y., Kloepfer A.M., Hinkle G., et al. A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell 2006, 124:1283-1298.
77. Walhout A.J., Temple G.F., Brasch M.A., Hartley J.L., Lorson M.A., van den Heuvel S., et al. GATEWAY recombinational cloning: application to the cloning of large numbers of open reading frames or ORFeomes. Methods Enzymol 2000, 328:575-592.
78. Burckstummer T., Bennett K.L., Preradovic A., Schutze G., Hantschel O., Superti-Furga G., et al. An efficient tandem affinity purification procedure for interaction proteomics in mammalian cells. Nat Methods 2006, 3:1013-1019.
79. Mak A.B., Moffat J. A versatile lentiviral expression system to identify mammalian protein-protein interactions. Methods 2012, 57:409-416.
80. Chacinska A., Koehler C.M., Milenkovic D., Lithgow T., Pfanner N. Importing mitochondrial proteins: machineries and mechanisms. Cell 2009, 138:628-644.
81. Marchal-Victorion S., Deleyrolle L., De Weille J., Saunier M., Dromard C., Sandillon F., et al. The human NTERA2 neural cell line generates neurons on growth under neural stem cell conditions and exhibits characteristics of radial glial cells. Mol Cell Neurosci 2003, 24:198-213.
82. Newington J.T., Pitts A., Chien A., Arseneault R., Schubert D., Cumming R.C. Amyloid beta resistance in nerve cell lines is mediated by the Warburg effect. PLoS One 2011, 6:e19191.
83. Karra D., Dahm R. Transfection techniques for neuronal cells. J Neurosci 2010, 30:6171-6177.
84. Washbourne P., McAllister A.K. Techniques for gene transfer into neurons. Curr Opin Neurobiol 2002, 12:566-573.
85. Miteva Y.V., Budayeva H.G., Cristea I.M. Proteomics-based methods for discovery, quantification, and validation of protein-protein interactions. Anal Chem 2013, 85:749-768.
86. Yoon Y., Krueger E.W., Oswald B.J., McNiven M.A. The mitochondrial protein hFis1 regulates mitochondrial fission in mammalian cells through an interaction with the dynamin-like protein DLP1. Mol Cell Biol 2003, 23:5409-5420.
87. Butland G., Peregrín-Alvarez J.M., Li J., Yang W., Yang X., Canadien V., et al. Interaction network containing conserved and essential protein complexes in Escherichia coli. Nature 2005, 433:531-537.
88. Beck M., Schmidt A., Malmstroem J., Claassen M., Ori A., Szymborska A., et al. The quantitative proteome of a human cell line. Mol Syst Biol 2011, 7:549.
89. Geiger T., Wehner A., Schaab C., Cox J., Mann M. Comparative proteomic analysis of eleven common cell lines reveals ubiquitous but varying expression of most proteins. Mol Cell Proteomics 2012, 11:M111. [014050].
90. Perkins D.N., Pappin D.J., Creasy D.M., Cottrell J.S. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 1999, 20:3551-3567.
91. Kwon T., Choi H., Vogel C., Nesvizhskii A.I., Marcotte E.M. MSblender: a probabilistic approach for integrating peptide identifications from multiple database search engines. J Proteome Res 2011, 10:2949-2958.
92. Eng J.K., McCormack A.L., Yates Iii J.R. An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J Am Soc Mass Spectrom 1994, 5:976-989.
93. Kim S., Mischerikow N., Bandeira N., Navarro J.D., Wich L., Mohammed S., et al. The generating function of CID, ETD, and CID/ETD pairs of tandem mass spectra: applications to database search. Mol Cell Proteomics 2010, 9:2840-2852.
94. Nesvizhskii A.I., Vitek O., Aebersold R. Analysis and validation of proteomic data generated by tandem mass spectrometry. Nat Methods 2007, 4:787-797.
95. Kislinger T., Rahman K., Radulovic D., Cox B., Rossant J., Emili A. PRISM, a generic large scale proteomic investigation strategy for mammals. Mol Cell Proteomics 2003, 2:96-106.
96. Mellacheruvu D., Wright Z., Couzens A.L., Lambert J.P., St-Denis N.A., Li T., et al. The CRAPome: a contaminant repository for affinity purification-mass spectrometry data. Nat Methods 2013, 10:730-736.
97. Collins S.R., Kemmeren P., Zhao X.C., Greenblatt J.F., Spencer F., Holstege F.C., et al. Toward a comprehensive atlas of the physical interactome of Saccharomyces cerevisiae. Mol Cell Proteomics 2007, 6:439-450.
98. Jager S., Cimermancic P., Gulbahce N., Johnson J.R., McGovern K.E., Clarke S.C., et al. Global landscape of HIV-human protein complexes. Nature 2011, 481:365-370.
99. Choi H., Larsen B., Lin Z.Y., Breitkreutz A., Mellacheruvu D., Fermin D., et al. SAINT: probabilistic scoring of affinity purification-mass spectrometry data. Nat Methods 2011, 8:70-73.
100. Breitkreutz B.J., Stark C., Reguly T., Boucher L., Breitkreutz A., Livstone M., et al. The BioGRID Interaction Database: 2008 update. Nucleic Acids Res 2008, 36:D637-D640.
101. Gavin A.C., Aloy P., Grandi P., Krause R., Boesche M., Marzioch M., et al. Proteome survey reveals modularity of the yeast cell machinery. Nature 2006, 631-636.
102. Vlasblom J., Wodak S.J. Markov clustering versus affinity propagation for the partitioning of protein interaction graphs. BMC Bioinformatics 2009, 10:99.
103. Enright A.J., Van Dongen S., Ouzounis C.A. An efficient algorithm for large-scale detection of protein families. Nucleic Acids Res 2002, 30:1575-1584.
104. Nepusz T., Yu H., Paccanaro A. Detecting overlapping protein complexes in protein-protein interaction networks. Nat Methods 2012, 9:471-472.
105. Brohee S., van Helden J. Evaluation of clustering algorithms for protein-protein interaction networks. BMC Bioinformatics 2006, 7:488.
106. Pu S., Vlasblom J., Emili A., Greenblatt J., Wodak S.J. Identifying functional modules in the physical interactome of Saccharomyces cerevisiae. Proteomics 2007, 7:944-960.
107. Kristensen A.R., Gsponer J., Foster L.J. A high-throughput approach for measuring temporal changes in the interactome. Nat Methods 2012, 9:907-909.
108. Formstecher E., Aresta S., Collura V., Hamburger A., Meil A., Trehin A., et al. Protein interaction mapping: a Drosophila case study. Genome Res 2005, 376-384.
109. Rajagopala S.V., Titz B., Goll J., Parrish J.R., Wohlbold K., McKevitt M.T., et al. The protein network of bacterial motility. Mol Syst Biol 2007, 3:128.
110. Rual J.F., Venkatesan K., Hao T., Hirozane-Kishikawa T., Dricot A., Li N., et al. Towards a proteome-scale map of the human protein-protein interaction network. Nature 2005, 1173-1178.
111. Lim J., Hao T., Shaw C., Patel A.J., Szabo G., Rual J.F., et al. A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration. Cell 2006, 125:801-814.
112. Soler-Lopez M., Zanzoni A., Lluis R., Stelzl U., Aloy P. Interactome mapping suggests new mechanistic details underlying Alzheimer's disease. Genome Res 2011, 21:364-376.
113. Yu Z., Liu N., Wang Y., Li X., Wang X. Identification of neuroglobin-interacting proteins using yeast two-hybrid screening. Neuroscience 2012, 200:99-105.
114. Yang X., Boehm J.S., Yang X., Salehi-Ashtiani K., Hao T., Shen Y., et al. A public genome-scale lentiviral expression library of human ORFs. Nat Methods 2011, 8:659-661.
115. Simonis N., Rual J.F., Carvunis A.R., Tasan M., Lemmens I., Hirozane-Kishikawa T., et al. Empirically controlled mapping of the Caenorhabditis elegans protein-protein interactome network. Nat Methods 2009, 6:47-54.
116. Venkatesan K., Rual J.F., Vazquez A., Stelzl U., Lemmens I., Hirozane-Kishikawa T., et al. An empirical framework for binary interactome mapping. Nat Methods 2009, 6:83-90.
117. Stynen B., Tournu H., Tavernier J., Van Dijck P. Diversity in genetic in vivo methods for protein-protein interaction studies: from the yeast two-hybrid system to the mammalian split-luciferase system. Microbiol Mol Biol Rev 2012, 76:331-382.
118. Washburn M.P. Driving biochemical discovery with quantitative proteomics. Trends Biochem Sci 2011, 36:170-177.
119. Cox J., Mann M. Quantitative, high-resolution proteomics for data-driven systems biology. Annu Rev Biochem 2011, 80:273-299.
120. Craft G.E., Chen A., Nairn A.C. Recent advances in quantitative neuroproteomics. Methods 2013, 61:186-218.
121. Pardo M., Choudhary J.S. Assignment of protein interactions from affinity purification/mass spectrometry data. J Proteome Res 2012, 11:1462-1474.
122. Ong S.E., Blagoev B., Kratchmarova I., Kristensen D.B., Steen H., Pandey A., et al. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics 2002, 1:376-386.
123. de Godoy L.M., Olsen J.V., Cox J., Nielsen M.L., Hubner N.C., Frohlich F., et al. Comprehensive mass-spectrometry-based proteome quantification of haploid versus diploid yeast. Nature 2008, 455:1251-1254.
124. Jin J., Davis J., Zhu D., Kashima D.T., Leroueil M., Pan C., et al. Identification of novel proteins affected by rotenone in mitochondria of dopaminergic cells. BMC Neurosci 2007, 8:67.
125. Van Hoof D., Pinkse M.W., Oostwaard D.W., Mummery C.L., Heck A.J., Krijgsveld J. An experimental correction for arginine-to-proline conversion artifacts in SILAC-based quantitative proteomics. Nat Methods 2007, 4:677-678.
126. Patel V.J., Thalassinos K., Slade S.E., Connolly J.B., Crombie A., Murrell J.C., et al. A comparison of labeling and label-free mass spectrometry-based proteomics approaches. J Proteome Res 2009, 8:3752-3759.
127. Shariatgorji M., Svenningsson P., Andren P.E. Mass spectrometry imaging, an emerging technology in neuropsychopharmacology. Neuropsychopharmacology 2009, 8.
128. Kallback P., Shariatgorji M., Nilsson A., Andren P.E. Novel mass spectrometry imaging software assisting labeled normalization and quantitation of drugs and neuropeptides directly in tissue sections. J Proteomics 2012, 75:4941-4951.
129. Hsieh Y., Casale R., Fukuda E., Chen J., Knemeyer I., Wingate J., et al. Matrix-assisted laser desorption/ionization imaging mass spectrometry for direct measurement of clozapine in rat brain tissue. Rapid Commun Mass Spectrom 2006, 20:965-972.
130. Tong A.H., Evangelista M., Parsons A.B., Xu H., Bader G.D., Page N., et al. Systematic genetic analysis with ordered arrays of yeast deletion mutants. Science 2001, 294:2364-2368.
131. Breslow D.K., Cameron D.M., Collins S.R., Schuldiner M., Stewart-Ornstein J., Newman H.W., et al. A comprehensive strategy enabling high-resolution functional analysis of the yeast genome. Nat Methods 2008, 5:711-718.
132. Li J., Yuan Z., Zhang Z. The cellular robustness by genetic redundancy in budding yeast. PLoS Genet 2010, 6:e1001187.
133. Babu M., Musso G., Diaz-Mejia J.J., Butland G., Greenblatt J.F., Emili A. Systems-level approaches for identifying and analyzing genetic interaction networks in Escherichia coli and extensions to other prokaryotes. Mol Biosyst 2009, 12:1439-1455.
134. Li Z., Vizeacoumar F.J., Bahr S., Li J., Warringer J., Vizeacoumar F.S., et al. Systematic exploration of essential yeast gene function with temperature-sensitive mutants. Nat Biotechnol 2011, 29:361-367.
135. Rothbauer U., Hofmann S., Muhlenbein N., Paschen S.A., Gerbitz K.D., Neupert W., et al. Role of the deafness dystonia peptide 1 (DDP1) in import of human Tim23 into the inner membrane of mitochondria. J Biol Chem 2001, 276:37327-37334.
136. Roesch K., Curran S.P., Tranebjaerg L., Koehler C.M. Human deafness dystonia syndrome is caused by a defect in assembly of the DDP1/TIMM8a-TIMM13 complex. Hum Mol Genet 2002, 11:477-486.
137. Knight S.A., Kim R., Pain D., Dancis A. The yeast connection to Friedreich ataxia. Am J Hum Genet 1999, 64:365-371.
138. Votruba M. Molecular genetic basis of primary inherited optic neuropathies. Eye 2004, 18:1126-1132.
139. Yu L., Lopez A., Anaflous A., El Bali B., Hamal A., Ericson E., et al. Chemical-genetic profiling of imidazo[1,2-a]pyridines and -pyrimidines reveals target pathways conserved between yeast and human cells. PLoS Genet 2008, 4:e1000284.
140. Henschel A., Buchholz F., Habermann B. DEQOR: a web-based tool for the design and quality control of siRNAs. Nucleic Acids Res 2004, 32:W113-W120.
141. Buchholz F., Kittler R., Slabicki M., Theis M. Enzymatically prepared RNAi libraries. Nat Methods 2006, 3:696-700.
142. Pan X., Yuan D.S., Ooi S.L., Wang X., Sookhai-Mahadeo S., Meluh P., et al. dSLAM analysis of genome-wide genetic interactions in Saccharomyces cerevisiae. Methods 2007, 206-221.
143. Mali P., Yang L., Esvelt K.M., Aach J., Guell M., DiCarlo J.E., et al. RNA-guided human genome engineering via Cas9. Science 2013, 339:823-826.
144. Joung J.K., Sander J.D. TALENs: a widely applicable technology for targeted genome editing. Nat Rev Mol Cell Biol 2013, 14:49-55.
145. Costanzo M., Baryshnikova A., Myers C.L., Andrews B., Boone C. Charting the genetic interaction map of a cell. Curr Opin Biotechnol 2011, 22:66-74.
146. Hannum G., Srivas R., Guenole A., van Attikum H., Krogan N.J., Karp R.M., et al. Genome-wide association data reveal a global map of genetic interactions among protein complexes. PLoS Genet 2009, 5:e1000782.
147. Pujana M.A., Han J.D., Starita L.M., Stevens K.N., Tewari M., Ahn J.S., et al. Network modeling links breast cancer susceptibility and centrosome dysfunction. Nat Genet 2007, 39:1338-1349.
148. Goehler H., Lalowski M., Stelzl U., Waelter S., Stroedicke M., Worm U., et al. A protein interaction network links GIT1, an enhancer of huntingtin aggregation, to Huntington's disease. Mol Cell 2004, 15:853-865.
149. Friedman J.R., Lackner L.L., West M., DiBenedetto J.R., Nunnari J., Voeltz G.K. ER tubules mark sites of mitochondrial division. Science 2011, 334:358-362.
150. Tabas I., Ron D. Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress. Nat Cell Biol 2011, 13:184-190.
151. Sasaki S. Endoplasmic reticulum stress in motor neurons of the spinal cord in sporadic amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 2011, 69:346-355.
152. Schon E.A., Przedborski S. Mitochondria: the next (neurode)generation. Neuron 2011, 70:1033-1053.
153. Chatr-Aryamontri A., Breitkreutz B.J., Heinicke S., Boucher L., Winter A., Stark C., et al. The BioGRID interaction database: 2013 update. Nucleic Acids Res 2013, 41:D816-D823.
154. Turner B., Razick S., Turinsky A.L., Vlasblom J., Crowdy E.K., Cho E., et al. iRefWeb: interactive analysis of consolidated protein interaction data and their supporting evidence. Database (Oxford) 2010, 2010:baq023.
155. Vizeacoumar F.J., Arnold R., Vizeacoumar F.S., Chandrashekhar M., Buzina A., Young J.T., et al. A negative genetic interaction map in isogenic cancer cell lines reveals cancer cell vulnerabilities. Mol Syst Biol. 2013, 9:696.